TABLE 1.
Outcome | Studies | WMD (95% CI) | p‐Value | I 2 (%) | p‐Value |
---|---|---|---|---|---|
OR 2–8 weeks | |||||
2 Weeks, MI | 2 | 0.99 (0.88–1.09) | .845 | 67 | .081 |
4 Weeks, MI | 2 | 0.99 (0.90–1.07) | .806 | 0 | .828 |
8 Weeks, MI and IS | 2 | 0.97 (0.94–1.01) | .142 | 0 | .627 |
IR 1–4 weeks | |||||
IS | 2 | 1.04 (0.98–1.10) | .191 | 15 | .277 |
MI | 2 | 0.97 (0.87–1.07) | .557 | 58 | .121 |
MI and IS (all) | 2 | 1.02 (0.92–1.13) | .722 | 61 | .031 |
IR 5–8 weeks | |||||
IS | 2 | 1.05 (1.01–1.09) | .014 | 0 | .682 |
MI | 2 | 1.05 (0.95–1.07) | .744 | 0 | .345 |
MI and IS (all) | 2 | 1.04 (0.97–1.10) | .191 | 55 | .132 |
Note: The fixed‐effect, inverse variance weighed pooled analysis was used, data given as WMD, p‐value, I 2 (heterogeneity), and CI. OR 1–7 days MI and IS and OR 2–8 weeks. IS could not be calculated due to different time periods. τ 2 could not be calculated because there were only two studies and fixed‐effect analysis was used.
Abbreviations: CI, confidence interval; IS, ischaemic stroke; MI, myocardial infarction; OR, odds ratio; WMD, weighed mean difference.
Bold value is statistically significant, pointing to increase in risk.